The DOI matches its Crossref record; 23 of the 24 references it cites were found in a registry or an index.
The anti-obesity agent Orlistat is associated to increase in colonic preneoplastic markers in rats treated with a chemical carcinogen
Abstract
Orlistat is an anti-obesity agent that increases the fecal fat excretion, which promotes colon carcinogenesis. Therefore, the present study was designed to verify the effects of Orlistat on the formation of rat colonic aberrant crypt foci (ACF) and cell proliferation evaluated by the PCNA method. Male Wistar rats received either a standard diet or a high fat diet (HFD), supplemented or not with Orlistat (200mg/kg chow) and two doses of the carcinogen dimethyl-hydrazine (25mg/Kg). After 30 days, Orlistat was associated to a significant increase in the number of colonic ACFs and cell proliferation in DMH-treated animals, independently of the HFD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In animal studies, orlistat was associated with clusters of apoptosis-resistant, neoplastic, and premalignant colonic lesions.
“In animal studies, orlistat was associated with clusters of apoptosis-resistant, neoplastic, and premalignant colonic lesions [27].”
From Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand? (2021) · cites this paper as [27]
Citations
Cites
Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity
Kridel, S. J., Axelrod, F. T., Rozenkrantz, N., & Smith, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3645 · Cited by 610
Orlistat, a New Lipase Inhibitor for the Management of Obesity
Heck, A. M., Yanovski, J. A., & Calis, K. A. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.4.270.34882 · Cited by 576
Padwal, R., Li, S. K., & Lau, D. C. W. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802475 · Cited by 348
Orlistat: its current status as an anti-obesity drug
Ballinger, A., & Peikin, S. R. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01422-x · Cited by 296
Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.
Rao, C. V., Hirose, Y., Indranie, C., & Reddy, B. S. (2001) · PubMed · Cited by 274
A Western-style diet induces benign and malignant neoplasms in the colon of normal C57Bl/6 mice
Newmark, H. L., Yang, K., Lipkin, M., Kopelovich, L., Liu, Y., Fan, K., & Shinozaki, H. (2001) · Carcinogenesis · doi:10.1093/carcin/22.11.1871 · Cited by 206
Singh, J., Hamid, R., & Reddy, B. S. (1997) · PubMed · Cited by 199
Melia, A. T., Koss‐Twardy, S. G., & Zhi, J. (1996) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1996.tb04230.x · Cited by 120
Vitamin D and Colon Carcinogenesis
Harris, D. M., & Go, V. L. W. (2004) · Journal of Nutrition · doi:10.1093/jn/134.12.3463s · Cited by 116
Bull, A. W., Nigro, N. D., Golembieski, W., Crissman, J. D., & Marnett, L. J. (1984) · PubMed · Cited by 114
Erhardt, J. G., Lim, S. S., Bode, J. C., & Bode, C. (1997) · Journal of Nutrition · doi:10.1093/jn/127.5.706 · Cited by 101
Comparative Evaluation of Fecal Fat Excretion Induced by Orlistat and Chitosan
Guerciolini, R., Radu‐Radulescu, L., Boldrin, M. N., Dallas, J., & Moore, R. (2001) · Obesity Research · doi:10.1038/oby.2001.47 · Cited by 77
Shpitz, B., Bomstein, Y., Mekori, Y., Cohen, R., Kaufman, Z., Grankin, M., & Bernheim, J. (1997) · The American Journal of Surgery · doi:10.1016/s0002-9610(97)00122-0 · Cited by 63
Nishioka, T., Hafkamp, A. M., Havinga, R., van Lierop, P. P. E., Velvis, H. J. R., & Verkade, H. J. (2003) · The Journal of Pediatrics · doi:10.1067/s0022-3476(03)00298-1 · Cited by 54
Shivapurkar, N., Tang, Z., Frost, A. R., & Alabaster, O. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)03729-g · Cited by 53
Demarzo, M., & Garcia, S. B. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.06.002 · Cited by 46
Self-citationSalim, A. S. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530629 · Cited by 41
Morotomi, M., Sakaitani, Y., Satou, M., Takahashi, T., Takagi, A., & Onoue, M. (1997) · Nutrition and Cancer · doi:10.1080/01635589709514507 · Cited by 34
Bays, H. E., & Dujovne, C. A. (2002) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200202040-00004 · Cited by 27
Orlistat for the long-term treatment of obesity
Harp, J. B. (1999) · Drugs of today · doi:10.1358/dot.1999.35.2.527969 · Cited by 24
Effective oral treatment of unconjugated hyperbilirubinemia in Gunn rats†
Hafkamp, A. M., Havinga, R., Sinaasappel, M., & Verkade, H. J. (2005) · Hepatology · doi:10.1002/hep.20589 · Cited by 23
Geter, D. R. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2003.11.006 · Cited by 14
William H. Thornton, Jr., & MacDonald, R. S. (1997) · Annals of Nutrition and Metabolism · doi:10.1159/000178002 · Cited by 9
Flagged first, then by citations
1 of the 24 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Orlistat-Associated Adverse Effects and Drug Interactions
Filippatos, T. D., Derdemezis, C. S., Gazi, I. F., Nakou, E. S., Mikhailidis, D. P., & Elisaf, M. (2008) · Drug Safety · doi:10.2165/00002018-200831010-00005 · Cited by 441
Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?
Tak, Y. J., & Lee, S. Y. (2021) · Current Obesity Reports · doi:10.1007/s13679-020-00422-w · Cited by 343
Anti-Obesity Drugs: Long-Term Efficacy and Safety: An Updated Review
Tak, Y. J., & Lee, S. Y. (2020) · The World Journal of Men s Health · doi:10.5534/wjmh.200010 · Cited by 198
Marine Algae as a Potential Source for Anti-Obesity Agents
Wan-Loy, C., & Siew-Moi, P. (2016) · Marine Drugs · doi:10.3390/md14120222 · Cited by 184
Obesity management: update on orlistat.
Drew, B. S., Dixon, A. F. R., & Dixon, J. B. (2007) · PubMed Central · Cited by 159
Matsumoto, M., Hosokawa, M., Matsukawa, N., Hagio, M., Shinoki, A., Nishimukai, M., Miyashita, K., Yajima, T., & Hara, H. (2009) · European Journal of Nutrition · doi:10.1007/s00394-009-0078-y · Cited by 135
gp130 receptor ligands as potential therapeutic targets for obesity
Febbraio, M. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30453 · Cited by 124
Safety and tolerability of new-generation anti-obesity medications: a narrative review
Patel, D. K., & Stanford, F. C. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2018.1435129 · Cited by 119
Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon
Izzo, A. A., Aviello, G., Petrosino, S., Orlando, P., Marsicano, G., Lutz, B., Borrelli, F., Capasso, R., Nigam, S., Capasso, F., et al. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0248-4 · Cited by 109
Kannen, V., Hintzsche, H., Zanette, D. L., Silva, W. A., Garcia, S. B., Waaga-Gasser, A. M., & Stopper, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050043 · Cited by 68
Self-citationDowling, S. C., Cox, J., & Cenedella, R. J. (2009) · Lipids · doi:10.1007/s11745-009-3298-2 · Cited by 67
Obesity and multiple myeloma: Emerging mechanisms and perspectives
Tentolouris, A., Ntanasis‐Stathopoulos, I., & Terpos, E. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.04.003 · Cited by 58
Kannen, V., Marini, T., Turatti, A., de Carvalho, M. C., Brandão, M. L., Jabor, V. A. P., Bonato, P. S., Ferreira, F. R., Zanette, D. L., Silva, W. A., et al. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.04.024 · Cited by 54
Self-citationEngin, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_1 · Cited by 56
Orsolin, P. C., Oliveira, R. G. S., & Nepomuceno, J. C. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.05.008 · Cited by 51
Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications
Halpern, B., & Halpern, A. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.994502 · Cited by 51
Aalim, H., Belwal, T., Jiang, L., Huang, H., Meng, X., & Luo, Z. (2019) · LWT · doi:10.1016/j.lwt.2019.01.006 · Cited by 48
Dietary sphingolipids: potential for management of dyslipidemia and nonalcoholic fatty liver disease
Norris, G. H., & Blesso, C. N. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nux004 · Cited by 48
Risk of colorectal cancer after initiation of orlistat: matched cohort study
Hong, J.-L., Meier, C. R., Sandler, R. S., Jick, S. S., & Sturmer, T. (2013) · BMJ · doi:10.1136/bmj.f5039 · Cited by 38
Pharmabiotics as an Emerging Medication for Metabolic Syndrome and Its Related Diseases
Nguyễn, T. T. B., Jin, Y., & Chung, H. (2017) · Molecules · doi:10.3390/molecules22101795 · Cited by 41
In Vivo Effectiveness of Orlistat in the Suppression of Human Colorectal Cancer Cell Proliferation
Czumaj, A., Zabielska, J., Pakiet, A., Mika, A., Rostkowska, O. M., Makarewicz, W., Kobiela, J., Śledziński, T., & Stelmańska, E. (2019) · Anticancer Research · doi:10.21873/anticanres.13531 · Cited by 38
Jin, B., Kim, H.-J., Sim, S.-A., Lee, M., & An, H. (2021) · Cells · doi:10.3390/cells10082060 · Cited by 37
Dietary restriction: could it be considered as speed bump on tumor progression road?
Cangemi, A. G., Fanale, D., Rinaldi, G., Bazan, V., Galvano, A., Perez, A., Barraco, N., Massihnia, D., Castiglia, M., Vieni, S., et al. (2016) · Tumor Biology · doi:10.1007/s13277-016-5044-8 · Cited by 37
Adel, A. M., & El-Shinnawy, N. A. (2012) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2012.08.003 · Cited by 34
Current pharmacotherapeutic concepts for the treatment of obesity in adults
Idelevich, E. A., Kirch, W., & Schindler, C. (2008) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944708098226 · Cited by 29
Chiou, S., Lai, J., Liao, J., Sung, J. M., & Lin, S. (2018) · Cereal Chemistry · doi:10.1002/cche.10025 · Cited by 26
Dadkhah, A., Allameh, A., Khalafi, H., & Ashrafihelan, J. (2010) · Nutrition and Cancer · doi:10.1080/01635581.2010.516473 · Cited by 25
Diet Induced Obesity Increases the Risk of Colonic Tumorigenesis in Mice
Sikalidis, A. K., Fitch, M. D., & Fleming, S. E. (2013) · Pathology & Oncology Research · doi:10.1007/s12253-013-9626-0 · Cited by 23
Glucagon-like peptide 2 in colon carcinogenesis: Possible target for anti-cancer therapy?
Kannen, V., Garcia, S. B., Stopper, H., & Waaga-Gasser, A. M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.04.007 · Cited by 21
Self-citationWu, C.-R., Lee, S., Chen, C., & Lin, S. (2023) · Foods · doi:10.3390/foods12030636 · Cited by 17
Martinello, F., Kannen, V., Franco, J. J., Gasparotto, B., Sakita, J. Y., Sugohara, A., Garcia, S. B., & Uyemura, S. A. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.07.005 · Cited by 17
Self-citationKannen, V., Zanette, D. L., Fernandes, C. R., Ferreira, F. R., Marini, T., de Carvalho, M. C., Brandão, M. L., Elías, J., Mauad, F. M., Silva, W. A., et al. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.06.014 · Cited by 17
Self-citationPharmacotherapy for Obesity: Past, Present and Future
Hsu, Y.-W., Chu, D.-C., Ku, P., Liou, T., & Chou, P. (2010) · Journal of Experimental & Clinical Medicine · doi:10.1016/s1878-3317(10)60019-8 · Cited by 15
Cioccoloni, G., Bonmassar, L., Pagani, E., Caporali, S., Fuggetta, M. P., Bonmassar, E., D’Atri, S., & Aquino, A. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3025 · Cited by 14
Bhattacharjee, K., Nath, M., & Choudhury, Y. (2021) · Phytomedicine Plus · doi:10.1016/j.phyplu.2021.100098 · Cited by 14
Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
Dvořák, Z., Klapholz, M., Burris, T. P., Willing, B. P., Gioiello, A., Pellicciari, R., Galli, F., March, J. C., O’Keefe, S. J., Sartor, R. B., et al. (2020) · Molecular Pharmacology · doi:10.1124/molpharm.120.000035 · Cited by 12
Playdon, M. C., Hardikar, S. S., Karra, P., Hoobler, R., Ibele, A. R., Cook, K. L., Kumar, A., Ippolito, J. E., & Brown, J. C. (2023) · JNCI Monographs · doi:10.1093/jncimonographs/lgad003 · Cited by 12
Anti-Obesity Drug Orlistat (Xenical) Is a Novel Antitumor Medication
Azadbakht, L., Jamali-Gojani, Z., & Heidari‐Beni, M. (2015) · Shiraz E-Medical Journal · doi:10.17795/semj26242 · Cited by 12
Kannen, V., Fernandes, C. R., Stopper, H., Zanette, D. L., Ferreira, F. R., Frajácomo, F. T. T., de Carvalho, M. C., Brandão, M. L., Elías, J., Jordão, A. A., et al. (2013) · Toxicology · doi:10.1016/j.tox.2013.08.014 · Cited by 11
Self-citationPineal gland function is required for colon antipreneoplastic effects of physical exercise in rats
Frajácomo, F. T. T., Garcia, W. N. D. P., Fernandes, C. R., Garcia, S. B., & Kannen, V. (2014) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.12348 · Cited by 9
Self-citationPartial lipectomy reduces dimethylhydrazine-induced carcinogenic initiation in the colon of rats
Kannen, V., Moreira, M. C. S., Waaga-Gasser, A. M., Modiano, P., Elías, J., Fernandes, C. R., & Garcia, S. B. (2013) · Toxicology · doi:10.1016/j.tox.2013.11.010 · Cited by 9
Self-citationKarimabad, M. N., Roostaei, F., Mahmoodi, M., & Hajizadeh, M. R. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.8.2335 · Cited by 4
Ledesma‐Aparicio, J., Mailloux‐Salinas, P., Arias‐Chávez, D. J., Campos‐Pérez, E., Calixto-Tlacomulco, S., Cruz‐Rangel, A., Reyes‐Grajeda, J. P., & Bravo, G. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70040 · Cited by 3
Smith, T. J., Walker, L. A., Cummins, D., Crombie, A. P., Funderburk, L., Young, A., & Touger-Decker, R. E. (2012) · Topics in Clinical Nutrition · doi:10.1097/tin.0b013e31826f8e02 · Cited by 2
Pharmacotherapy of Childhood Obesity and Pre-diabetes
Freemark, M. (2010) · Springer eBooks · doi:10.1007/978-1-60327-874-4_23 · Cited by 2
The metabolic effect of medicinal plants and synthetic anti-obesity products on human health
Al-Shammary, Z. A. A., & Alshammaa, D. A. S. (2024) · Plant Science Today · doi:10.14719/pst.3206 · Cited by 4
Bhattacharjee, K., Nath, M., Sharan, R. N., & Choudhury, Y. (2025) · Toxicon · doi:10.1016/j.toxicon.2025.108636 · Cited by 1
Li, L., & Hao, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1944242 · Cited by 1
Lovastatin, but not orlistat, reduces intestinal polyp volume in an ApcMin/+ mouse model
Notarnicola, M., Barone, M., Francavilla, A., Tutino, V., Bianco, G., Tafaro, A., Minoia, M., Polimeno, L., Napoli, A., Scavo, M. P., et al. (2016) · Oncology Reports · doi:10.3892/or.2016.4856 · Cited by 1
Metabolic syndrome and cancer risk
Majumder, A., & Acharya, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00052-9 · Cited by 1
Efeitos do exercício físico associado à luz contínua na carcinogênese colônica em ratos
Frajácomo, F. T. T. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2010.tde-04082014-153535
Hasan, E. I., Zaher, J., Eshak, G. A., & El‐Tahawy, N. F. G. (2011) · Mansoura Journal of Forensic Medicine and Clinical Toxicology · doi:10.21608/mjfmct.2011.55875
Kannen, V., Hintzsche, H., Zanette, D. L., Silva, W. A., Garcia, S. B., Waaga-Gasser, A. M., & Stopper, H. (2013) · PLoS ONE · doi:10.1371/annotation/919e5cc0-39bb-4465-babe-d2bdf12e89ff
Self-citationGut Microbiome and Obesity: Connecting Link
Mishra, J., Amin, K., Kuang, L., & Kumar, N. (2022) · Springer eBooks · doi:10.1007/978-981-19-3979-2_4
Abdulshaheed, H. G. (2023) · Al-Qadisiyah Journal Of Pure Science · doi:10.29350/2411-3514.1004
Progress in Anti-Obesity Drug Development: A Pharmacodynamics Perspective
Ahmad, I., Azmi, S., Albabtain, M. A., Mustafa, M., Kunnathodi, F., Riyasdeen, A., AlWhaiby, B. R., Alharbi, E. M., Arafat, A. A., & Alotaibi, H. F. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18101281
Metadata
- Authors
- Garcia, S. B., da Costa Barros, L. T., Turatti, A., Martinello, F., Modiano, P., Ribeiro-Silva, A., de Oliveira Vespúcio, M. V., & Uyemura, S. A.
- Affiliations
- Universidade de São Paulo (BR)
- Corresponding author
- Garcia, Sérgio Britto
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2006-08
- Volume
- 240
- Issue
- 2
- Pages
- 221-224
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2060102560
- Cited by
- 57
- References
- 24
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 4 · 2023: 4 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 3 · 2016: 3 · 2015: 3 · 2014: 1 · 2013: 6 · 2012: 5
- FWCI
- 1.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Letters (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- orlistat, colon carcinogenesis, dimethylhydrazine, high-fat diet, fecal fat excretion, cell proliferation, PCNA, precancerous lesions, anti-obesity drugs
- MeSH terms
- Orlistat, Animals, Carcinogens, Colonic Neoplasms, Intestinal Mucosa, Lactones, Lipase, Male, Precancerous Conditions, Rats, Wistar, Proliferating Cell Nuclear Antigen, Anti-Obesity Agents, 1,2-Dimethylhydrazine, Cell Proliferation, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review